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Abstract
Background: Metronidazole (MET) and Diloxanide Furoate (DF), act as antiprotozoal drugs, in their ternary mixtures
with Mebeverine HCl (MEH), an effective antispasmodic drug. This work concerns with the development and
validation of two simple, specific and cost effective methods mainly for simultaneous determination of the
proposed ternary mixture. In addition, the developed multivariate calibration model has been updated to
determine Metronidazole benzoate (METB) in its binary mixture with DF in Dimetrol
® suspension.
Results: Method (I) is the mean centering of ratio spectra spectrophotometric method (MCR) that depends on using
the mean centered ratio spectra in two successive steps that eliminates the derivative steps and therefore the signal
to noise ratio is enhanced. The developed MCR method has been successfully applied for determination of MET, DF
and MEH in different laboratory prepared mixtures and in tablets. Method (II) is the partial least square (PLS)
multivariate calibration method that has been optimized for determination of MET, DF and MEH in Dimetrol
® tablets
and by updating the developed model, it has been successfully used for prediction of binary mixtures of DF and
Metronidazole Benzoate ester (METB) in Dimetrol
® suspension with good accuracy and precision without
reconstruction of the calibration set.
Conclusion: The developed methods have been validated; accuracy, precision and specificity were found to be
within the acceptable limits. Moreover results obtained by the suggested methods showed no significant
difference when compared with those obtained by reported methods.
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Mebeverine Hydrochloride (MEH), an effective antispas-
modic drug that acts directly on the smooth muscle of
gastrointestinal tract and is used in conditions such as
irritable bowel syndrome [1]. DF, a luminal amoebicide,
it is a dichloroacetamide derivative that principally acts
in the bowel lumen and is used in the treatment of
intestinal amoebicide [1]. Metronidazole (MET), an
effective antiprotozoal drug, it is 5- nitroimidazole deri-
vative with activity against anaerobic bacteria and proto-
zoa [1] and is useful in both intestinal and extra
intestinal amoebiasis. METB is a benzoyl ester of metro-
nidazole that has the same action and uses [2,3], but
mainly used in pediatric oral preparations because of
the bland taste of the ester compared to the bitter taste
of the free base [4]. Although both DF and MET act as
antiprotozoal drugs, however their combination has a
synergistic effect and acts on both vegetative and cystic
forms of entamoeba histolytica [5].
Up to our knowledge, the literature survey revealed
that none of the most recognized pharmacopoeies
reported an analytical method for determination of the
studied drugs in their ternary mixtures. On the other
hand, only one journal published a report for determina-
tion of the studied mixture using TLC-Densitometric
and derivative ratio spectrophotometric methods [6]. All
other reported methods have been developed only for
determination of each of the proposed drugs either
alone or in combination with other drugs. British phar-
macopoeia [7] reported non aqueous titration methods
for determination each of the studied drugs in its dosage
form; also USP [8] reported the same technique for
determination of DF, MET and METB. MEH was
recently determined by several techniques including,
RP-HPLC [9-12], spectrophotometric, [13] and HPTLC
[12] methods. MET was determined in plasma [14-16],
blood [17] fish muscles [18], procine liver [19] and in
different pharmaceutical preparations using different
HPLC techniques, [20-23]. Also it has been determined
by spectrophotometric [23,24] and voltametric methods
[25]. Binary mixtures of DF and MET have been ana-
lyzed by RP-HPLC [5,26-28], spectrophotometric
[5,28-30] and TLC-Densitometric techniques [5]. Due to
the pharmaceutical importance of the studied drugs, this
work aims to develop and validate accurate and precise
methods for determination of MEH, DF and MET in
Dimetrol
® tablets, moreover, it aims to update the
developed PLS model to be used for determination of
DF and METB in Dimetrol
® suspension without recon-
struction of the calibration set. The developed MCR
method has the advantages of being simpler and selec-
tive than the published spectrophotometric one and it
does not need any derivatization steps, hence signal to
noise ratio is enhanced. The developed methods do not
need sophisticated instruments or any separation step
and so can be used as alternative methods to LC meth-
ods in laboratories lacking the required facilities for
these techniques.
Experimental
Instruments
A double beam UV-Visible spectrophotometer (SHI-
MADZU, Japan), model UV-1601 PC with 1 cm path
length quartz cell is used and it is connected to IBM
compatible computer. The software was UVPC personal
spectroscopy software version 3.7. Matlab
® version
R2007b [31] was used for the proposed chemometric
methods, the PLS was performed with PLS_Toolbox
[32] for use with Matlab
® R2007b.
Chemicals and reagents
Pure samples
Standards MEH, DF, MET and METB with claimed
purities of 98.9, 100.5, 100.4 and 99.3%, respectively
according to manufacturer certificate and were kindly
donated by EVA PHARMA for Pharmaceuticals and
Medical Appliances S.A.E, Egypt).
Market sample
1-Dimetrol
® film coated tablets batch No. 909537, were
labeled to contain 375 mg MET, 250 mg DF and 50 mg
MEH per tablet were manufactured by EVA PHARMA for
Pharmaceuticals and Medical Appliances S.A.E, Egypt.
2- Dimetrol
® Suspension batch No. 906001 and
908403, was labeled to contain 200 mg METB and 100
mg DF per 5 mL suspension and was manufactured by
EVA PHARMA for Pharmaceuticals and Medical Appli-
ances S.A.E, Egypt.
Methanol
HPLC grade (Sigma-Aldrich
® Chemie GmbH, Germany).
Solutions
-Stock standard solutions of MEH, DF, MET and METB
were prepared in methanol in the concentration of 1 mg
mL
-1.
-Working standard solutions of MEH, DF, MET and
METB were prepared in methanol in the concentration
of 0.1 mg mL
-1.
Procedure
Mean centering of ratio spectra method (MCR)
Calibration model
Accurate aliquots equivalent to 10-250 μg each of MEH,
DF and MET were transferred from their respective
working standard solutions (0.1 mg mL
-1) into three ser-
ies of 10-mLvolumetric flasks, the volume was com-
pleted to the mark with methanol to obtain final
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-1 for each drug. The
absorption spectra of the prepared solution were mea-
sured in the range of 216 - 315 nm.
For MEH: the recorded spectra were divided by stan-
dard spectrum of 6 μgm L
-1 MET to obtain the first
ratio spectra which was then mean centered. These vec-
tors (mean centered ratio spectra) were then divided by
the mean centered (MC) ratio of (aDF/aMET)c o r r e -
sponding to 6 μgm L
-1 each, then the mean centering of
the second ratio spectra were then obtained. By the
same way, the recorded spectra of DF were divided by
the standard spectrum of 20 μgm L
-1 MET and the
obtained ratio spectra were mean centered, these vectors
were divided by the mean centered ratio of (aMEH/
aMET) corresponding to 20 μgm L
-1 each to obtain the
second ratio spectra which were then mean centered.
For MET, the scanned spectra of its prepared solutions
were divided by the normalized spectrum of MEH and
the obtained ratio spectra were mean centered. These
vectors were divided by the mean centered ratio of
(aDF/aMEH) corresponding to normalized spectrum each
and the second ratio spectra were then mean centered.
The mean centered values of the second ratio spectra
at 293-311 (peak to peak), 280 and 255-299 nm (peak to
peak) for MEH, DF and MET, respectively were mea-
sured and plotted against the corresponding concentra-
tion of each drug to construct their respective
calibration graphs.
Laboratory prepared mixtures
Different laboratory prepared mixtures containing differ-
ent ratios each of MEH, DF and MET within their cali-
bration ranges were prepared. The spectra of these
mixtures were then recorded and the procedure under
construction of calibration curves was then followed but
using the recorded spectra of the prepared mixtures.
PLS model
Calibration model
Multilevel multifactor design was used for construction
of the calibration and validation sets [33]. A five-level,
three-factor calibration design was used in order to pre-
pare 25 laboratory prepared mixtures containing differ-
ent ratios of the three studied drugs, the concentrations
details are given in Table 1. The absorption spectra of
the prepared mixtures in the range of 230-300 nm were
recorded; the spectral data acquisition was taken with
0.4 nm interval and then transferred to Matlab
®R2007b
for subsequent data manipulation. Seventeen mixtures
were used for building the calibration model.
Assay of validation set
The remaining eight laboratory prepared mixtures,
T a b l e1 ,w e r ec h o s e nt ob eu s e da sa ne x t e r n a lv a l i d a -
tion set and the procedure given under construction of
calibration set was then followed. The concentrations of
each component were calculated using the optimized
PLS calibration model.
Model updating
To perform model updating, the optimized PLS calibration
set was augmented with different samples of Dimetrol
®
syrup containing known amounts each of DF and METB.
One to six samples containing different concentrations of
each were added to the initial calibration set and the pre-
dictive ability of the updated model was checked using
external validation samples (prepared from Dimetrol
® sus-
pension with different batch number) their concentrations
were previously determined using the reported RP-HPLC
method [29]. The RMSEP values were then calculated for
each component using the developed model with different
numbers of the added updating samples.
Application to market samples
Dimetrol
® tablets
The content of twenty coated tablets of Dimetrol
® was
separately weighed. An accurately weighted portion
Table 1 Concentrations of Mebeverine HCl, Diloxanide
Furoate and Metronidazole in the calibration and
validation sets
Sample No. MEH (μgm L
-1)D F ( μgm L
-1) MET (μgm L
-1)
1 3 11 15
23 72 5
3 2 15 25
4* 2 11 20
5 4 15 20
6 4 13 25
7* 3 13 10
8 3.5 15 15
9 4 11 10
10 3 9 20
11 2.5 13 20
12 3.5 13 5
13* 3.5 9 10
14* 2.5 9 25
15 2.5 7 15
16 3.5 7 20
17* 2.5 11 5
18 2 13 15
19 3.5 11 25
20 3 15 5
21 4 7 5
22* 2.5 15 10
23 2 7 20
24* 4 9 15
25 2 9 5
* Samples used for model validation
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MEH were separately transferred into 100-mL calibrated
measuring flask and then 75 mL methanol was added.
The prepared solution was sonicated for 30 minutes, the
volume was completed with methanol and the solution
was then filtered. Appropriate dilution of the prepared
solution was made to prepare the working solution (0.1
mg mL
-1) of DF and the corresponding concentration of
MET and MEH (0.15 and 0.02 mg mL
-1, respectively).
Dimetrol
® suspension
5m Lo fD i m e t r o l
® suspension was accurately trans-
ferred (after vigorous shaking) into a 100 mL measuring
flask, sonicated in 50 mL methanol for 10 min and fil-
tered into another 100 mL volumetric flask. The residue
was washed using (3 × 10) mL methanol and the
volume was completed to the mark with methanol.
Appropriate dilutions of the prepared solution were
made to prepare the working solution (0.1 mg mL
-1)o f
DF and the corresponding concentration of METB.
Results and Discussion
The UV absorption spectra of MEH, DF, MET and
M E T B ,F i g u r e1 ,d i s p l a y sc o n s iderable overlap, where
the application of conventional spectrophotometry, its
direct derivative and derivative ratio techniques failed to
resolve these overlapping.
Mean centering of ratio spectra spectrophotometric
method (MCR)
The developed MCR method depends on the mean cen-
tering of ratio spectra, it eliminates the derivative steps
and therefore signal-to-noise ratio is enhanced [34] and
it has been applied for resolving binary and ternary mix-
tures in complex samples with unknown matrices [35].
The mathematical explanation of the method was illu-
strated by Afkhami and Bahram [34-36].
In order to optimize the developed MCR method,
effect of divisor concentration on the selectivity of the
method has been tested. Different concentrations each
of MEH, DF and MET (normalized spectrum, 4, 6, 8, 14
and 20 μgm L
-1) were tested. It was found that the divi-
sor had a great effect on the selectivity of determination
of MEH and DF where reproducible and good results
have been obtained upon using concentration of 6 μg
mL
-1 each of MET and DF (for MEH) and 20 μgm L
-1
each of MET and MEH (for DF) as divisors. On the
other hand, changing the concentration of the divisor
had no significant effect on the specificity of MET
determination, therefore, normalized spectrum each of
MEH and DF was used as a divisor.
Beer’sL a m b e r t ’s law has been obeyed in the range of
1-24, 2-25 and 1-24 μgm L
-1 f o rM E H ,D Fa n dM E T ,
respectively, Figure 2. Calibration curves relating the
mean centered values at 293-311 (peak to peak)), 280
and 255-299 nm (peak to peak) to the corresponding
concentrations of MEH, DF and MET, respectively have
been constructed from which the regression equation
parameters found in Table 2 have been obtained. Speci-
ficity of the method has been validated by application
on different synthetic mixtures containing different
ratios of the three studied drugs where good percentage
recoveries with law RSD% values were obtained, Table
Figure 1 Zero order absorption spectra of 22.5 μgm L
-1 MET (), 15 μgm L
-1 DF (————), 3 μgm L
-1 MEH (......) and 22.5 μgm L
-1
METB (-.-.-.) in methanol.
Abdelaleem and Abdelwahab Chemistry Central Journal 2012, 6:27
http://journal.chemistrycentral.com/content/6/1/27
Page 4 of 83. Moreover, accuracy of the suggested method has been
confirmed by its application for determination of blind
samples of pure drugs and good results were obtained,
Table 2. The results obtained on applying the developed
MCR method for determination of pure MEH, DF and
MET on different days confirmed the precision of the
method, Table 2.
Partial least squares (PLS)
Recently quantitative spectroscopy has been greatly
improved by the use of variety of multivariate statistical
methods [37-39]. This work aims to investigate the abil-
ity of PLS model to quantify each of MEH, DF and
MET with overlapping UV spectra, Figure 1, in Dime-
trol
® tablets and to apply the optimized PLS model for
determination of DF and METB in Dimetrol
® suspen-
sion by performing model updating.
The first step in the determination of the cited drugs
by multivariate calibration method is to construct the
calibration matrix for the ternary mixture (MEH, DF
and MET), calibration set was obtained by using the
absorption spectra of seventeen laboratory prepared
mixtures (using five level, three-factor calibration
design) of different ratios each of MEH, DF and MET in
the range of 230-300 nm and the spectral data acquisi-
tion was taken with 0.4 nm interval. The regions from
200 nm- 229 nm and above 300 nm were rejected. In
this study, the data was auto scaled as a pre- processing
step, leave one out cross validation method was applied
and the root mean squared error of calibration RMSEC
values of the initially developed models were compared.
The selected model was that with the smallest number
of factors such that RMSEC for that model was not sig-
nificantly greater than RMSEC from model with an
additional factor. Four factors were selected by F-test
for PLS [40]. The second step is to assess the prediction
ability of the suggested model, an external validation set
consisting of different eight prepared mixtures was used
and the root mean squared error of prediction (RMSEP)
values were calculated, Table 3, where the results
obtained indicated the high predictive ability of the
developed model.
In order to apply the developed method for determi-
nation of DF and METB in Dimetrol
® suspension model
updating was performed.
Model-updating
Model updating [41] means predicting a new compo-
nent without reconstruction of calibration set. In this
work the model-updating was applied to predict the
concentration of the modeled compound, DF, in another
dosage form which had different spectral characteristic,
Figure 3, that contains this drug in addition to an un-
modeled one (METB) without reconstruction of the cali-
bration set.
The minimum number of samples needed to effi-
ciently update the developed model must be accurately
determined and the influence of number of samples
added to the calibration set on RMSEP was studied for
the developed multivariate calibration model. The num-
ber of different samples added shows a large impact on
the predictive ability of the updated model as shown in
(a)
 
(b) 
 
 
(c)
Figure 2 The mean centered second ratio absorption spectra
of)a) MEH, (b) DF and (c) MET in methanol.
Table 2 Regression and analytical parameters of the
proposed MCR method for determination of Mebeverine
HCl, Diloxanide Furoate and Metronidazole
Parameters MCR Method
MEH DF MET
Calibration range 1-24 2-25 1-24
μgmL
-1 μgmL
-1 μgmL
-1
Slope 22.726 4.6825 1095
Intercept 6.136 0.4945 -6.5508
Correlation coefficient 0.9998 0.9999 0.9999
Accuracy 99.13 100.12 100.50
Precision
Repeatability 0.991 0.879 0.799
Intermediate precision 1.205 1.003 1.220
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perform an efficient update of the developed PLS model.
The results of analysis of Dimetrol
® suspension by the
updated model are presented in Table 5.
The two developed methods are valid and applicable
for the analysis of the studied drugs in Dimetrol
® tablets
and suspension. The validity of the methods was
assessed by applying the standard addition technique,
Tables 3 and 4, which showed that the developed meth-
ods are accurate and specific for determination of the
cited drugs in presence of dosage form excipients. The
results obtained by the developed methods for analysis
of Dimetrol
® tablets and suspension have been com-
pared to those obtained by applying the reported meth-
ods [6,29] using Student’s-t and F tests and no
significant difference was found, Tables 3 and 4.
Table 3 Determination of the studied drugs in the laboratory prepared mixtures (L.P. M) and tablets by the proposed
methods and statistical comparison with the reported method
Parameters MCR method PLS method
MEH DF MET MEH DF MET
L.P.M
a 99.91 ± 2.338 100.88 ± 2.149 102.39 ± 1.780 99.85 ± 2.368 101.40 ± 1.311 100.54 ± 2.194
RMSEP 0.063 0.200 0.459
Dimetrol
® tablets
b (B.No.909537) 98.49 ± 1.419 100.15 ± 1.332 99.45 ± 1.127 99.33 ± 1.329 99.44 ± 0.965 100.78 ± 1.575
Standard addition
a 99.23 ± 1.122 101.50 ± 2.701 100.02 ± 1.752 102.54 ± 0.638 100.00 ± 1.858 98.90 ± 0.996
Degree of freedom 10 10 10 10 10 10
F-test
(5.050)
c 2.037 2.506 1.061 1.786 1.315 2.070
Degree of freedom Student’s -t test (2.228)
c 10 10 10 10 10 10
1.905 1.137 0.376 0.755 0.758 2.007
a: Average of 3 determinations
b: Average of 6 determinations
c: The values in the parenthesis are the corresponding theoretical values at p = 0.05
Figure 3 The average spectra of Dimetrol
® tablets (- - - - -) and Dimetrol
® suspension (____) in methanol.
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The presented methods are accurate, precise and sensi-
tive which are applicable for simultaneous determination
of MEH, DF and MET. The developed MCR method
has the advantages over the published methods in being
more simple, rapid and the data processing step is not
time consuming as it does not need the application of
complex algorithms. Also, it does not need derivative
steps and so signal to noise ratio has enhanced. On the
other hand, the developed PLS model has the advan-
tages of being cost and time effective because only one
model has been used for resolution of the studied tern-
ary mixture and then by updating the model, it could be
successfully applied for determination of DF and METB
binary mixture in another dosage form.
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